financetom
Business
financetom
/
Business
/
US FDA declines to approve Orexo's opioid overdose drug
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
US FDA declines to approve Orexo's opioid overdose drug
Jul 16, 2024 1:23 PM

July 16 (Reuters) - The U.S. Food and Drug

Administration has declined to approve Orexo AB's

high-dose prescription drug for opioid overdose, the company

said on Tuesday.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved